Notice: Release of draft revised guidance documents on Post-Notice of Compliance (NOC) Changes – Quality, for stakeholder consultation

Health Canada is pleased to announce the release of five associated revised draft guidance documents on Post-Notice of Compliance (NOC) Quality Changes for pharmaceutical, biologic and radiopharmaceutical drugs for human use, for stakeholder consultation.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis : Publication des ébauches révisées des lignes directrices sur les Changements survenus après l’avis de conformité (AC) – Document sur la qualité, aux fins d’une consultation des intervenants
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-07-30 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["projet de directives révisées", "post-avis de conformité", "changements pour les produits pharmaceutiques", "changements pour les produits biologiques", "changements pour les produits radiopharmaceutiques", "médicaments à usage humain", "pour consultation des parties prenantes"], "en": ["draft revised guidance", "post-notice of compliance", "changes for pharmaceutical", "changes for biologic", "changes for radiopharmaceutical", "drugs for human-use", "for stakeholder consultation"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source